New Delhi: “Indian medical devices industry has the power to emerge as the global leader in manufacturing and innovation in next 25 years. It has the potential to grow at 28 per cent per annum to reach $50 bn by 2030.” This as stated by Dr Mansukh Mandaviya, Union Minister for Chemicals & Fertilisers and Health & Family Welfare as he launched the website of India MedTech Expo 2022 (IMTE-22) and released the flyer for the event. The first ever expo being spearheaded by the Government in association with Indian medical devices industry, the three-day IMTE-22 will start from December 9, 2022 at Pragati Maidan, New Delhi.
The three-day long IMTE-22 is the first edition of India MedTech Expo, organised by Dept of Pharmaceuticals, Govt of India in close association with all the Medical Devices Industry Associations. It is being coordinated by the Federation of Indian Chambers of Commerce & Industry (FICCI).
Dr Mandaviya stated, “The event will create visibility of medical devices ecosystem to the world and build a brand identity for the Indian MedTech sector. The Indian medical devices sector’s contribution has become even more prominent since India supported the domestic and global battle against COVID-19 pandemic through the production of medical devices & diagnostic kits, such as ventilators, rapid antigen test kits, RT-PCR kits, IR thermometers, PPE kits & N-95 masks.”
IMTE-22 is planned around the theme ‘Future of Device, Diagnostics & Digital’. The event will create opportunities to network and explore collaborations both for the sector’s growth in India and its potential contribution globally, by bringing together all the stakeholders such as PLI participants, start-ups, MSMEs, Innovative entrepreneurs, R&D facilities, Incubators, public and private hospitals, industry at large, academia, research institutions, investors, State governments, MedTech parks and key government officials to deliberate on key sectoral issues, collaborate & create opportunities to not only make India truly self-reliant but also transform it into a global med-tech hub by 2047.
The Minister pointed out that India has its strengths of skilled manpower, ease of business through its industry-friendly rules and also offers a huge market. The Expo will provide a platform for the various global leaders in this sector to converge and explore India’s potential as a manufacturing hub, and also an emerging global market.”
The Union Minister emphasised that India has the potential to be one of the top 20 global medical device markets in a short span of time and urged the Indian Medical Devices Industry to work with an aim to emerge as the global leader in the manufacturing and innovation of medical devices. The Minister expressed confidence in the ability of the Indian Medical Devices Industry to achieve 10-12 per cent share in the expanding global market over the next 25 years.
The purpose of India MedTech Expo is to showcase the strength and potential of Indian MedTech Industry, the innovation ecosystem of the country and a strong academia which is nurturing entrepreneurship relentlessly. IMTE-22 is expected to have participation of more than 450 Indian MedTech companies including big companies, MSMEs and start-ups.
Medical devices constitute a multi-disciplinary sector with the following broad classification: (a) electronic equipment (b) implants; (c) consumables and disposables (d) surgical instruments and (e) in-vitro diagnostic reagents. Several segments in the medical device industry are highly capital intensive with long gestation period, requiring continuous induction of new technologies and training of healthcare professionals to adapt to new technologies and bring rapid innovation. Medical devices undergo safety, quality and efficacy tests through processes defined by the regulator before they get placed in the market for sale.The current market size of the medical devices sector in India is estimated to be $ 11 bn and its share in the global medical device market is estimated to be 1.5 per cent. The sector in India is witnessing fast growth with CAGR of 10-12 per cent over the last decade.
At the event, S Aparna, Secretary, Department of Pharmaceuticals reiterated on how the Department has been working to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.